tiprankstipranks
Trending News
More News >
THC Farmaceuticals Inc (CBDG)
OTHER OTC:CBDG
US Market

THC Farmaceuticals (CBDG) Income Statement

Compare
22 Followers

THC Farmaceuticals Income Statement

Last quarter (Q3 2022), THC Farmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, THC Farmaceuticals's net income was $-3.16K. See THC Farmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
$ 0.00$ 10.00K$ 2.23K$ 7.58K$ 10.19K
Gross Profit
$ -4.95K$ 6.19K$ 1.28K$ 7.58K$ 7.56K
Operating Expenses
$ -25.00K$ 14.68K$ 19.09K$ 39.32K$ 165.65K
Depreciation and Amortization
$ 4.95K$ 3.81K$ 952.00$ 952.00$ 953.00
EBITDA
$ -25.00K$ 429.87K$ -15.85K$ -119.70K$ -994.19K
Operating Income
$ -29.95K$ -8.49K$ -17.81K$ -32.70K$ -158.09K
Other Income/Expenses
$ 0.00$ 434.55K$ 1.00K$ -87.95K$ -837.05K
Pretax Income
$ -29.95K$ 426.06K$ -16.81K$ -120.65K$ -995.14K
Net Income
$ -14.98K$ 426.90K$ -8.42K$ -60.45K$ -498.57K
Per Share Metrics
Basic EPS
$ 0.00$ 0.02$ 0.00$ 0.00$ -0.03
Diluted EPS
$ 0.00$ 0.02$ 0.00$ 0.00$ -0.03
Weighted Average Shares Outstanding
18.13M 18.13M 18.13M 16.63M 16.63M
Weighted Average Shares Outstanding (Diluted)
18.13M 18.13M 18.13M 16.63M 16.63M
Currency in USD

THC Farmaceuticals Earnings and Revenue History